Knowledge • News • Insights

In Partnership With

Your questions + our expertise = solutions. Click here to find your solutions. Foster Swift.

MichBio | BioLink – August 2022

MICHBio_loloo Cropped

Join the Michigan Pavilion at MEDICA!
 
APPLY BY AUGUST 30 FOR THE NOVEMBER 12-18 SHOW IN GERMANY
Companies in the medical sector are invited to position their products and services in front of interested buyers and partners within the Michigan Pavilion at MEDICA. Coordinated by the MEDC, the Michigan Pavilion is a 101-square meter that will be placed in a prime location next to the US Commercial Service booth – your company’s branded kiosk could be part of the group representing Michigan.
 
WHY ATTEND?
  • As the largest medical trade show in the world, MEDICA attracts thousands of exhibitors from more than 50 countries.
  • Leaders from the fields of business, research, and politics convene here, alongside thousands of international experts and decision-makers.
  • The extensive exhibition hosts an ambitious program that presents the entire spectrum of innovations for outpatient and clinical care.
  • Visitors attracted to the show include general practitioners, hospital doctors and managers, laboratory managers, medical specialized trade, and more.
AREAS OF FOCUS AT MEDICA
  • Imaging and diagnostics
  • Medical equipment and devices
  • IT systems and solutions
  • Laboratory equipment
  • Physiotherapy/orthopedic tech
FEE INFORMATION
  • $2,500 participation fee includes exhibition, welcome reception, and B2B service.
  • Eligible companies may receive up to 75% reimbursement for participation and travel expenses through MI-STEP.
 
 
Michigan Medical Device Summit Agenda Announced!
NEW THIS YEAR – SUPPLIER SHOWCASE
 
You can now view the Agenda for the upcoming Michigan Medical Device Summit!
 
The Michigan Medical Device Summit is the annual gathering of the statewide medtech community. It is designed for attendees to learn about the latest in medical device technologies, regulations, and marketplace, and especially what Michigan’s cluster has to offer to those developing and manufacturing innovative medical products. Hear the state’s most outstanding medtech and related thought leaders share their perspectives on topics of the day.
 
Meet and network with medtech sector professionals, academic researchers, healthcare providers and clinicians, suppliers and contract manufacturers, professional services firms, investors, business leaders, and government officials, and disruptive companies across all growth stages.
 
The Summit is intended to better connect and raise the visibility of Michigan’s large medtech cluster including its significant innovation and supply chain assets that are contributing to its steady growth and economic impact. New in 2022 is a showcase of Michigan firms supplying and serving the medtech community.
 
*Speakers will be added as they confirm availability and provide biographical information.
 
 
Help Pass Copay Accumulator Legislation
SEPTEMBER 14 – LANSING
 
Join the Michigan All Copays Count Coalition on September 14 to help pass House Bill 4353; legislation in support of helping patients pay for life-saving medication!
 
House Bill 4353 ensures that any payment made by you, or on your behalf, counts towards your deductible and out-of-pocket costs by prohibiting a harmful practice known as copay accumulator adjustments. The bill passed the House in March 2021 and has since been sitting in the Senate Health Policy and Human Services Committee for over a year without receiving a hearing!
 
We need YOU to help build support for HB 4353 by sharing your story with your state senator!
 
EVENT DETAILS:
  • The day will include a morning issue briefing and breakfast with special guest Representative Bronna Kahle, legislative meetings with your state representative and senator, and a luncheon with the full Michigan All Copays Count Coalition.
  • This event is NO COST for Michigan patients and providers.
 
Register to attend the MACC legislative day and help us share the importance of copay assistance that counts.
 
 
Aon Human Capital Solutions provides MichBio members with market-leading data, analytics, and advice to usher in the new era of workforce transformation.
JOIN TODAY TO ACCESS AON SERVICES AT A DISCOUNT
 
As a leader in human capital and risk assessment, Aon offers insights on growth opportunities for life science businesses. In their recent news brief, What’s Ahead for Life Sciences? These Five Trends Are Shaping the Industry, Aon experts point to key trends that are relevant for our industry.
 
A Snapshot: What You Need to Know
  1. 71% of life science companies are planning to increase their workforce, but this has been a challenge. “The industry as a whole needs to continue to hire key critical talent and replace vacant roles, but then you place workforce disruption, a new working model and fierce competition for talent on top,” Meaghan Piscitelli, Aon Partner, says.
  2. Life science companies need to prioritize upskilling to meet the need for tech talent either through the hiring process or through employee development. Academia may be also be a future pipeline for producing life science professionals with strong digital talents.
  3. Employee values have shifted. Potential hires are looking for hybrid work options, wellbeing programs, and strong DEI commitments from employers.
 
Discounts on Aon Services for MichBio Members
  • 10% off on consulting fees addressing employee rewards, sales force compensation, talent assessment, rewards strategy, and more.
  • 7.5% off on compensation survey participation.
  • Access to select Aon articles and research, including insights from the Radford Global Compensation Database
 
 
 
 
 
 
 
 
 
 
 
 
FEDERAL ADVOCACY NEWS
 
Senate Considers Drug Pricing Controls Legislation
In the waning days before the August recess, Senate Democrats are pushing legislation with anti-science drug price controls, as part of a so-called reconciliation bill.
 
The legislation could undercut its own goals by depriving drugmakers of incentives for developing blockbuster medicines, plus lower-cost biosimilars and generics, several analysts and industry groups have warned. Predictions are that small, early-stage biotechs would take a

What's Hot

Get the latest news from MBN right in your inbox

Sign up for our newsletter and never miss a beat.